Skip to content

Equine Parasite Management: Fecal Egg Counts Over Blanket Treatment

Parasite Management at a Glance

90%+
Horses Shed Eggs
200 EPG
Treatment Threshold
2–4x/Year
Targeted Deworming
<$50/Year
FEC Test Cost
Fecal egg count (FEC) testing replaces the old blanket-deworming approach. Targeted treatment preserves drug efficacy and reduces resistance.
Fecal Count
FEC Test
Targeted Dosing
Herd Program
Quarterly Plan
$
Lower Cost

Deworming Efficacy Decline

Ivermectin 99% Moxidectin 98% Pyrantel 80% Fenbendazole 50% Oxibendazole 40%

Comparison

Approach Method Pros Cons
Targeted (FEC) Test then treat high shedders only Reduces resistance, lower cost, better herd health Requires FEC testing infrastructure
Interval (Scheduled) Deworm every 6–8 weeks on schedule Simple to manage Drives resistance, expensive, may be unnecessary
Strategic Seasonal Treat at key transmission times Evidence-based timing Requires regional knowledge
Blanket (All Horses) Same drug for every horse same day Quick to implement Highest resistance risk, wasteful

FEC-Based Program

FEC Test High Shedder? Deworm Retest 14 Day Pasture Mgmt

Parasite Management Checklist

FEC test all horses 2–4x per year
Treat only horses with >200 EPG
Rotate dewormer drug classes (avoid same class twice)
Fecal egg count reduction test 14 days after treatment
Pick manure from pastures weekly
Compost manure away from horse housing
Test new horses before introducing to herd
Target 80% of parasites come from 20% of horses (high shedders)
⚠️ Anthelmintic resistance is a critical threat. 50% of strongyle populations in some US farms are resistant to fenbendazole.
βœ… 20% of horses shed 80% of the eggs. Identifying and treating only those high shedders is the most effective herd strategy.

For decades, the standard advice was to deworm every horse every 6-8 weeks on a rotating drug schedule. Research over the past 20 years has overturned this: strategic deworming based on fecal egg counts (FEC) is now the evidence-based standard recommended by the American Association of Equine Practitioners, the British Equine Veterinary Association, and most parasitology researchers. Blanket treatment of all horses regardless of worm burden accelerates resistance development in parasites -- a problem already serious enough that some refugia-based resistance protocols are becoming necessary on affected properties.

Shedder Level EPG Range Treatment Approach
Low shedder Under 200 EPG Once yearly β€” 60–70% of horses; leave untreated to preserve refugia
Moderate shedder 200–500 EPG Twice yearly β€” spring and fall timed to pasture risk
High shedder Over 500 EPG 3–4 treatments/year; disproportionate pasture contaminators
Resistance check Pre vs. 14-day post-treatment <95% reduction (ivermectin) = suspected resistance on property
60–70% low shedders
Most horses on any property β€” blanket treatment of these horses accelerates resistance with no benefit
FEC spring + fall
Minimum testing schedule β€” spring guides summer treatment, fall guides autumn timing and encysted larval treatment
95% reduction check
Post-treatment benchmark β€” below 95% after ivermectin means resistance is present on your property

The Parasite Landscape

The primary equine parasites in mature horses (over age 3) are large strongyles (Strongylus vulgaris and related species) and small strongyles (cyathostomins, approximately 50 species). S. vulgaris causes the most serious pathology -- larval migration through the mesenteric arteries causes verminous arteritis and can produce life-threatening colic. Cyathostomins are ubiquitous, present in virtually all horses, and cause larval cyathostominosis (larval emergence en masse from encysted L3 stages in the gut wall) which causes severe protein-losing colitis, particularly in late winter and early spring.

Ascarids (Parascaris spp.) are primarily a problem in foals and horses under age 3, who have not yet developed natural immunity. Adult horses shed few Parascaris eggs. Tapeworms (Anoplocephala perfoliata) require a fecal egg count approach using modified McMaster flotation with specific solutions, or an EquiSal salivary antibody test for accurate detection. Pinworms (Oxyuris equi) cause perianal pruritus but minimal systemic harm; they are diagnosed by tape impression test rather than standard FEC.

Fecal Egg Counts: The Foundation of Strategic Deworming

A fecal egg count (FEC) performed by flotation and McMaster or Mini-FLOTAC technique reports eggs per gram (EPG) of feces. In practice, horses fall into one of three shedder categories: Low shedders (under 200 EPG): approximately 60-70% of horses on any property. These horses have natural immunity that limits worm burdens and require less frequent treatment -- typically once yearly. Moderate shedders (200-500 EPG): 20-25% of horses. Standard treatment twice yearly at spring and fall. High shedders (above 500 EPG): 10-15% of horses, these individuals disproportionately contaminate the pasture. Treatment 3-4 times yearly with strategic timing.

FEC should be performed in spring (April-May) and fall (September-October) as a minimum. The spring FEC guides the level of treatment needed for summer pasture season; the fall FEC guides autumn treatment timing. FEC reduction testing -- comparing EPG before and 14 days after treatment -- is the practical way to detect anthelmintic resistance on individual properties. A reduction below 95% after ivermectin treatment or below 90% after benzimidazole treatment indicates suspected resistance.

Current Drug Classes and Resistance Status

Three drug classes are available for equine deworming: Benzimidazoles (fenbendazole, oxibendazole): resistance is widespread globally in cyathostomins (some studies show greater than 90% of properties with benzimidazole-resistant cyathostomins). Tetrahydropyrimidines (pyrantel pamoate): moderate resistance in cyathostomins. Macrocyclic lactones (ivermectin, moxidectin): most effective against the broadest spectrum, but resistance is increasing. Moxidectin is the most potent macrocyclic lactone and is the only drug effective against encysted cyathostomin L3 stages at standard doses.

Praziquantel is added to some ivermectin and moxidectin products (Equimax, Quest Plus) specifically for tapeworm coverage -- it has no activity against strongyles. Encysted small strongyle treatment (larval cyathostominosis prevention) requires either moxidectin (single dose) or a 5-day fenbendazole treatment at twice the normal dose. Strategic timing of encysted larval treatment is typically in late autumn or early winter before larvae emerge.

Refugia: Protecting Drug Efficacy

Refugia refers to the population of parasites not exposed to treatment at a given time -- parasites in eggs on pasture, larvae on grass, and worms in untreated horses. Maintaining refugia is essential to slowing resistance development. Blanket treatment of all horses simultaneously eliminates refugia and creates intense selection pressure for resistance alleles. Strategic treatment of high shedders only, while leaving low shedders untreated, preserves refugia by maintaining susceptible parasites in the population. This counterintuitive approach is now the recommended standard in evidence-based parasite management.

Sources: AAEP Internal Parasite Control Guidelines 2019; Nielsen et al. (2010) Veterinary Parasitology review of strategic deworming; Kaplan and Nielsen (2010) Equine Veterinary Education on evidence-based deworming; Merck Veterinary Manual equine parasitology; Love and Murphy, Monitoring Equine Anthelmintic Efficacy (BEVA guidelines).

Share:

Want more pet care tips?

Join thousands of pet parents who get practical pet care guides every week. No spam β€” unsubscribe anytime.